Newsroom

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Olympus Cosmetic Group, a surgeon-led partnership platform purpose-built for leading aesthetic surgery practices, has signed an agreement with AI Med Consult to introduce its AI-powered patient engagement technology across its growing network of 18 locations. The partnership supports Olympus' commitment to equipping surgeon partners with innovative resources that enhance patient experience, strengthen practice operations, and support long-term growth. “We’...

ORLANDO, Fla.--(BUSINESS WIRE)--Marriott Vacations Worldwide Corporation (NYSE: VAC) (“MVW,” the “Company,” “we” or “our”) reported financial results for the third quarter of 2026. Third Quarter 2026 Highlights Contract sales increased 29% year over year to $565 million in the quarter. VPG was $4,822, 30% above last year. Development profit increased 97% to $142 million versus the prior year. Net income attributable to common stockholders was $82 million compared to net loss attributable to com...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced four poster presentations at the 2026 NEI Fall Congress taking place November 5 through 8 in Colorado Springs, CO. Positive topline results from Panorama, the Company’s second Phase 3 study of DT120 (lysergide...

HAMILTON, Bermuda--(BUSINESS WIRE)--Assured Guaranty Ltd. (NYSE:AGO) today declared a quarterly dividend of $0.38 per common share. The dividend is payable on December 2, 2026 to shareholders of record at the close of business on November 18, 2026.Assured Guaranty Ltd. is a publicly traded (NYSE: AGO), Bermuda-based holding company. Through its subsidiaries, Assured Guaranty provides credit enhancement products to the U.S. and non-U.S. public finance, infrastructure and structured finance market...

ATLANTA--(BUSINESS WIRE)--Smith Douglas Homes Corp. (NYSE: SDHC) (“Smith Douglas” or the “Company”) today announced third quarter results for the three and nine months ended September 30, 2026. Q3 2026 Results as compared to Q3 2025: Home closings increased 5% to 831 Home closing revenue increased 0.2% to $262.5 million Home closing gross margin of 16.3% compared to 21.0% Net new home orders increased 13% to 777 Backlog homes increased 25% to 947 Pretax income of $3.3 million compared to $17.2...

MISSION WOODS, Kan.--(BUSINESS WIRE)--Palmer Square Capital BDC Inc. (NYSE: PSBD) (“PSBD” or the “Company”), an externally managed business development company, today announced its financial results for the third quarter ended September 30, 2026. Financial and Operating Highlights Total investment income of $26.6 million for the third quarter of 2026, compared to $31.7 million for the prior year period Net investment income of $11.6 million or $0.38 per share for the third quarter of 2026, comp...

NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield Ltd. (NYSE: CWK) today reported financial results for the third quarter of 2026. Diluted earnings per share (“EPS”) was $0.22, flat with prior year, while Adjusted EPS was $0.37, up 28%. “Today we reported our seventh consecutive quarter of double-digit adjusted earnings per share growth, showcasing the power of our balanced platform and strategy. With $800 million in debt paydowns since 2024 our balance sheet has been transformed, and we enter...

BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Frontier Medicines Corporation (Frontier), a clinical-stage, AI-powered precision medicines company that discovers and develops covalent medicines for previously undruggable and hard-to-drug disease-causing targets, starting with cancer, today announced that it will present preclinical data from its FMC-242 program at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place in Barcelona, Spain, from Novem...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that it has entered into an amendment with Arena Pharmaceuticals, Inc. (Arena), a subsidiary of Pfizer Inc., which eliminates all royalty obligations under its exclusive license agreement related to ralinepag in exchange for an up-front payment of $525 million. “This transaction demonstrates our confidence in the revenue opportunity for...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2026. Frank H. Laukien, Bruker’s President and CEO, commented: “Bruker drives significant advances in post-genomic drug discovery and disease biology research, from proteoforms to glycobiology, and from functional protein interactions to spatial biology. These deeper insights into molecular, cell and tissue biology are foundational for successf...